THERYQ

THERYQ is a medical technology company located in the south of France, specializing in the design and production of advanced radiotherapy machines that utilize particle accelerators, particularly linear accelerators. As a spin-off from PMB-ALCEN and part of ALCEN’s Healthcare branch, THERYQ focuses on enhancing cancer treatment outcomes through innovative technology. The company excels in project management, research and development, industrialization, and manufacturing of radiotherapy systems. THERYQ aims to address challenges in conventional radiotherapy, such as the need for multiple treatment sessions and the potential damage to healthy tissues. Their products are designed to improve the precision and effectiveness of cancer treatment, particularly for aggressive cancers like glioblastoma. THERYQ serves healthcare providers and cancer treatment centers, collaborating with research institutions like CERN and CHUV to advance innovations in cancer radiotherapy. Their commitment to improving patient care is reflected in their development of technologies that can safely deliver higher energy doses to tumors, ultimately enhancing treatment efficacy and patient outcomes.

• Employees 39
• Founded 2022